array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3435)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(54) "Roche factory in Penzberg: Group invests in Nonnenwald"
["snippet_en"]=>
string(129) "The Roche Group can look back on a good 2023 financial year. The company is investing 600 million euros in its plant in Penzberg."
["url"]=>
string(122) "https://www.merkur.de/lokales/dasgelbeblatt/oberland/roche-werk-in-penzberg-konzern-investiert-im-nonnenwald-92840461.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/658ae5f2-fd1c-440e-a20f-bd5e2973e089"
["source"]=>
string(9) "merkur.de"
["publication_date"]=>
string(10) "2024-02-19"
["categories"]=>
array(6) {
[0]=>
string(20) "Business Development"
[1]=>
string(18) "Financial Distress"
[2]=>
string(18) "General Investment"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(19) "Investment Requests"
[5]=>
string(18) "Expansion & Growth"
}
}
[1]=>
array(7) {
["title_en"]=>
string(64) "Roche to fold struggling diabetes business into diagnostics unit"
["snippet_en"]=>
string(126) "In 2017, the company considered options for the business including a sale, people close to the deliberations said at the time."
["url"]=>
string(128) "https://www.financialexpress.com/healthcare/diagnostic/roche-to-fold-struggling-diabetes-business-into-diagnostics-unit/3353273/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d96dc3a4-4b12-42b6-b194-c7a1f2582e45"
["source"]=>
string(20) "financialexpress.com"
["publication_date"]=>
string(10) "2024-01-02"
["categories"]=>
array(3) {
[0]=>
string(22) "Business Restructuring"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[2]=>
array(7) {
["title_en"]=>
string(63) "Roche to Pick Up ‘Troubled’ LumiraDx POCT Platform Business"
["snippet_en"]=>
string(101) "Roche said it would pick LumiraDx's point-of-care platform business in a deal valued at $350 million."
["url"]=>
string(88) "https://www.mddionline.com/ma/roche-to-pick-up-troubled-lumiradx-s-poc-platform-business"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fb4d9fef-42a2-4ef5-a0f7-64005fcf2868"
["source"]=>
string(14) "mddionline.com"
["publication_date"]=>
string(10) "2023-12-29"
["categories"]=>
array(4) {
[0]=>
string(41) "E-commerce and Technological Developments"
[1]=>
string(22) "Business Restructuring"
[2]=>
string(25) "Business Model Resilience"
[3]=>
string(20) "Business Development"
}
}
[3]=>
array(7) {
["title_en"]=>
string(65) "Roche bundles problem diabetes business into diagnostics division"
["snippet_en"]=>
string(159) "The Roche Group will integrate its previously independent diabetes business into its broader diagnostics division after a decade and a half of declining sales."
["url"]=>
string(109) "https://www.bloomberg.com/news/articles/2023-12-29/roche-bundelt-problemgeschaft-diabetes-in-diagnostiksparte"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2474e24f-3567-4899-98c1-afed9fc29f2a"
["source"]=>
string(13) "bloomberg.com"
["publication_date"]=>
string(10) "2023-12-29"
["categories"]=>
array(3) {
[0]=>
string(22) "Business Restructuring"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[4]=>
array(7) {
["title_en"]=>
string(74) "Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio"
["snippet_en"]=>
string(72) "The leading site for news and procurement in the pharmaceutical industry"
["url"]=>
string(128) "https://www.pharmaceutical-technology.com/newsletters/signal-lilly-searches-for-new-obesity-drugs-in-partnership-with-fauna-bio/"
["image_url"]=>
NULL
["source"]=>
string(29) "pharmaceutical-technology.com"
["publication_date"]=>
string(10) "2023-12-22"
["categories"]=>
array(6) {
[0]=>
string(11) "Acquisition"
[1]=>
string(20) "Business Development"
[2]=>
string(15) "Market Movement"
[3]=>
string(13) "Collaboration"
[4]=>
string(21) "Competitive Behaviour"
[5]=>
string(15) "Deals & Tenders"
}
}
[5]=>
array(7) {
["title_en"]=>
string(38) "Bioscience and pharmaceutical Archives"
["snippet_en"]=>
string(26) "Delaware's Business Source"
["url"]=>
string(73) "https://www.delawarebusinesstimes.com/news/bioscience-and-pharmaceutical/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d8d6f706-04ae-450d-b87f-2cdb438e3379"
["source"]=>
string(25) "delawarebusinesstimes.com"
["publication_date"]=>
string(10) "2023-12-14"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(15) "Deals & Tenders"
[2]=>
string(20) "Business Development"
}
}
[6]=>
array(7) {
["title_en"]=>
string(88) "Roche enters the obesity business after paying up to 2.8 billion for Carmot Therapeutics"
["snippet_en"]=>
string(88) "Roche enters the obesity business after paying up to 2.8 billion for Carmot Therapeutics"
["url"]=>
string(63) "https://www.merca2.es/2023/12/06/roche-obesidad-carmot-1503621/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d9e43cf9-2cdb-4739-8f4a-146fed83ab90"
["source"]=>
string(9) "merca2.es"
["publication_date"]=>
string(10) "2023-12-05"
["categories"]=>
array(3) {
[0]=>
string(11) "Acquisition"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[7]=>
array(7) {
["title_en"]=>
string(58) "Micro business celebrated at Brilliance in Business Awards"
["snippet_en"]=>
string(130) "4 December 2023. We recently sponsored the 'Best New Forest Micro Business' award at the New Forest Brilliance in Business Awards."
["url"]=>
string(100) "https://www.newforest.gov.uk/article/3458/Micro-business-celebrated-at-Brilliance-in-Business-Awards"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/22e7ac86-f9df-45e2-90cc-be827feceea6"
["source"]=>
string(16) "newforest.gov.uk"
["publication_date"]=>
string(10) "2023-12-04"
["categories"]=>
array(3) {
[0]=>
string(5) "Award"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[8]=>
array(7) {
["title_en"]=>
string(80) "ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target"
["snippet_en"]=>
string(95) "ShapeTX announces the expansion of its drug discovery partnership with Roche with new target..."
["url"]=>
string(152) "https://www.globenewswire.com/news-release/2023/11/30/2788521/0/en/ShapeTX-Expands-Strategic-Collaboration-with-Roche-with-Addition-of-a-New-Target.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/91567923-fe5e-4e20-a559-6dec6d2ac116"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2023-11-30"
["categories"]=>
array(3) {
[0]=>
string(13) "Collaboration"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(20) "Business Development"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(62)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(39)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3435 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
The Roche Group will integrate its previously independent diabetes business into its broader diagnostics division after a decade and a half of declining sales.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
